Clinical Trials Directory

Trials / Conditions / Female Sexual Arousal Disorder

Female Sexual Arousal Disorder

11 registered clinical trials studyying Female Sexual Arousal Disorder2 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingEvaluation of the Efficacy in Increasing Sexual Arousal, Safety and Tolerability of BZ371A in Women With Sexua
NCT06651541
Biozeus Biopharmaceutical S.A.Phase 2
RecruitingEvaluation of the Efficacy, Safety and Tolerability of BZ371A in Women with Sexual Arousal Disorder
NCT06116045
Biozeus Biopharmaceutical S.A.Phase 2
CompletedExamining Caffeine as a Treatment for Antidepressant-induced Arousal Dysfunction in Women
NCT05685407
University of Texas at AustinPhase 1
UnknownMulti-Center Study to Evaluate the Efficacy and Safety of Sildenafil Cream (3.6%) in Premenopausal Patients Wi
NCT04948151
Strategic Science & Technologies, LLCPhase 2
UnknownClinical Trial to Investigate the Effectiveness of a Dietary Supplement in Increasing Libido and Sexual Functi
NCT03820453
Kern Pharma, S.L.N/A
TerminatedSexual Penetration Pain in Postmenopausal Women: A Topical Botanical Drug Treatment
NCT03682601
GTO Pharmaceutical, LLCPhase 2
CompletedHeart Rate Variability Biofeedback for Female Sexual Arousal Disorder
NCT02958176
University of Texas at AustinN/A
CompletedBremelanotide in Premenopausal Women With Female Sexual Arousal Disorder and/or Hypoactive Sexual Desire Disor
NCT01382719
Palatin Technologies, IncPhase 2
TerminatedAlprostadil (FemLife Gel) in the Treatment of Female Sexual Arousal Disorder
NCT00572377
Cedars-Sinai Medical CenterPhase 1
CompletedEffects of Early Abuse on Adult Intimate Relationships
NCT01803802
University of Texas at AustinN/A
CompletedStudy to Investigate Effect of Sildenafil on Clitoral Engorgement as Measured by Magnetic Resonance Imaging (M
NCT00640458
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.Phase 2